Scholar Rock Holding Corp (NASDAQ:SRRK) — Market Cap & Net Worth
Market Cap & Net Worth: Scholar Rock Holding Corp (SRRK)
Scholar Rock Holding Corp (NASDAQ:SRRK) has a market capitalization of $4.69 Billion ($4.69 Billion) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3721 globally and #1305 in its home market, demonstrating a -14.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Scholar Rock Holding Corp's stock price $49.37 by its total outstanding shares 102007457 (102.01 Million). Also see Scholar Rock Holding Corp asset portfolio for a full breakdown of the balance sheet.
Scholar Rock Holding Corp Market Cap History: 2018 to 2026
Scholar Rock Holding Corp's market capitalization history from 2018 to 2026. Data shows growth from $2.34 Billion to $5.04 Billion (14.94% CAGR). Also see Scholar Rock Holding Corp (SRRK) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Scholar Rock Holding Corp is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.18% | #96 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.01% | #430 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.88 Trillion | 0.25% | #63 of 263 |
Weight: Scholar Rock Holding Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Scholar Rock Holding Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Scholar Rock Holding Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Scholar Rock Holding Corp (SRRK) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
27.81x
Scholar Rock Holding Corp's market cap is 27.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.34 Billion | $20.49 Million | -$49.70 Million | 65.61x | N/A |
| 2020 | $4.95 Billion | $15.40 Million | -$84.99 Million | 321.39x | N/A |
| 2021 | $2.53 Billion | $18.82 Million | -$131.80 Million | 134.67x | N/A |
| 2022 | $923.17 Million | $33.19 Million | -$131.65 Million | 27.81x | N/A |
Competitor Companies of SRRK by Market Capitalization
Companies near Scholar Rock Holding Corp in the global market cap rankings as of September 18, 2026. Review SRRK goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Scholar Rock Holding Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.34 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.87 Billion USD ( AU$84.62 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.09 Billion | $513.26 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.34 Billion | $774.61 |
| #457 | CSL Ltd | AU:CSL | $59.87 Billion | AU$174.41 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $145.62 |
Scholar Rock Holding Corp Historical Marketcap From 2018 to 2026
Between 2018 and today, Scholar Rock Holding Corp's market cap moved from $2.34 Billion to $ 5.04 Billion, with a yearly change of 14.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.04 Billion | +12.08% |
| 2025 | $4.49 Billion | +1.92% |
| 2024 | $4.41 Billion | +129.89% |
| 2023 | $1.92 Billion | +107.73% |
| 2022 | $923.17 Million | -63.57% |
| 2021 | $2.53 Billion | -48.82% |
| 2020 | $4.95 Billion | +268.21% |
| 2019 | $1.34 Billion | -42.62% |
| 2018 | $2.34 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Scholar Rock Holding Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.69 Billion USD |
| MoneyControl | $4.69 Billion USD |
| MarketWatch | $4.69 Billion USD |
| marketcap.company | $4.69 Billion USD |
| Reuters | $4.69 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to deve… Read more